{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:11:01Z","timestamp":1787800261338,"version":"build-2784847793"},"reference-count":38,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Chromatography"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>The goal of the presented methodology was to evolve and verify a simple, environmentally friendly, white HPLC stability\u2010indicating technology that can identify the mutagenic contaminant allyl bromide in both raw materials and parenteral rocuronium bromide medications. The mobile phase composition was ethyl alcohol and double\u2010distilled water in a ratio of 35%:65% at a flow rate of 1.0\u2009mL\/min. The linearity range concentrations of allyl bromide were 1.25\u201310\u2009\u03bcg\/mL. The injectable volume was 20\u2009\u03bcL, and the injection run time and total run time were less than 9\u2009min. With a retention time of allyl bromide at 7.11\u2009min, the detection wavelength was 210\u2009nm. The method's BAGI degree was 77.5, the MoGAPI degree was 82 with seven green sections, the final AES degree was 87, the AGSA degree was 80.56, the CaFRI degree was 86, the CACI degree was 77, and the whiteness score was 97.1. The HPLC method features simple implementation, environmental sustainability, and compliance with ICH Q2(R2), ICH M7, and US FDA validation criteria. It offers advantages like shorter retention time, reduced reagent use, microscale sample preparation, and lower costs compared to complex systems like UPLC\u2010MS.<\/jats:p>","DOI":"10.1002\/bmc.70418","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T11:03:46Z","timestamp":1773140626000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Novel and Sustainable HPLC Method for Monitoring Mutagenic Impurity in Injectable Medicines and Raw Ingredients via Microscale Preparation: Assessment via Greenness Tools"],"prefix":"10.1002","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9000-3777","authenticated-orcid":false,"given":"Ahmed\u00a0Sobhy","family":"Darwish","sequence":"first","affiliation":[{"name":"Department of Chemistry, Faculty of Science Zagazig University  Zagazig Egypt"},{"name":"EIPICO, Egyptian International Pharmaceutical Industries Company  10th of Ramadan City Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7312-3413","authenticated-orcid":false,"given":"Sherief\u00a0M.","family":"Abdel\u2010Raheem","sequence":"additional","affiliation":[{"name":"Department of Public Health, College of Veterinary Medicine King Faisal University  Al\u2010Ahsa Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham","family":"Ismail","sequence":"additional","affiliation":[{"name":"Department of Public Health, College of Veterinary Medicine King Faisal University  Al\u2010Ahsa Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faleh\u00a0A.","family":"Ameen","sequence":"additional","affiliation":[{"name":"Department of Agribusiness and Consumer Sciences, College of Agriculture and Food Sciences King Faisal University  Al\u2010Ahsa Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0010-0506","authenticated-orcid":false,"given":"Mahmoud\u00a0Samir\u00a0A.","family":"Zaki","sequence":"additional","affiliation":[{"name":"Department of Anatomy, College of Medicine King Khalid University  Abha Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wageh\u00a0Sobhy","family":"Darwish","sequence":"additional","affiliation":[{"name":"Department of Food Hygiene, Safety abd Technology, Faculty of Veterinary Medicine Zagazig University  Zagazig Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talo.2025.100407"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780198506980.001.0001"},{"key":"e_1_2_11_4_1","unstructured":"British Pharmacopoeia Medicines and Healthcare Products Regulatory Agency the Stationery Office on behalf of the MHRA London.2025. \u201cValidation of Analytical Procedures.\u201dhttps:\/\/www.pharmacopoeia.com\/bp\u20102025\/supplementary\u2010chapters\/sc\u20103\/sc\u2010iii\u2010f\u2010\u2010validation\u2010of\u2010analytical\u2010procedures.html?date=2025\u201004\u201001&text=VALIDATION."},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2026.116848"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.5c06752"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.70267"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2025.102985"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.21608\/bfszu.2025.357849.1475"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2025.114716"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.70152"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498258209038955"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00534271"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2012.03.013"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2013.04.010"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/1044\u20100305(91)85003\u2010O"},{"key":"e_1_2_11_17_1","unstructured":"Google Patents.2025. Accessed November 6 2025.https:\/\/patents.google.com\/patent\/CN106950314A\/en."},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.21608\/bfszu.2025.343593.1456"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2025.102739"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talo.2025.100538"},{"key":"e_1_2_11_21_1","unstructured":"International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use.2023a. \u201cAssessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk M.7(R2).\u201d"},{"key":"e_1_2_11_22_1","unstructured":"International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use.2023b. \u201cICH Harmonized Tripartite Guideline\u2010Validation of Analytical Procedures: Text and Methodology Q2 (R2).\u201d"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talo.2025.100565"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2025.102338"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1039\/D3GC02347H"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scp.2025.102051"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sampre.2025.100164"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13065\u2010025\u201001486\u20102"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/analytica5030030"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2021.116223"},{"key":"e_1_2_11_31_1","unstructured":"SIELC Technologies.2025a. Accessed November 5 2025.https:\/\/sielc.com\/hplc\u2010determination\u2010of\u2010allyl\u2010bromide."},{"key":"e_1_2_11_32_1","unstructured":"SIELC Technologies.2025b. Accessed November 5 2025.https:\/\/sielc.com\/separation\u2010of\u2010allyl\u2010bromide\u2010on\u2010newcrom\u2010r1\u2010hplc\u2010column."},{"key":"e_1_2_11_33_1","unstructured":"The Free Encyclopedia.2025. \u201cAllyl Bromide.\u201d Accessed November 5 2025.https:\/\/en.wikipedia.org\/wiki\/Allyl_bromide."},{"key":"e_1_2_11_34_1","unstructured":"The National Library of Medicine.2025. \u201cAllyl Bromide.\u201d Accessed November 5 2025.https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK576136\/."},{"key":"e_1_2_11_35_1","doi-asserted-by":"crossref","unstructured":"The United States Pharmacopeia United Stated Pharmacopeial Convention North Bethesda Maryland United States USPNF.2025a. \u201cValidation of Compendial Procedures.\u201dhttps:\/\/doi.org\/10.31003\/USPNF_M99945_04_01.","DOI":"10.31003\/USPNF_M99945_04_01"},{"key":"e_1_2_11_36_1","doi-asserted-by":"crossref","unstructured":"The United States Pharmacopeia United Stated Pharmacopeial Convention North Bethesda Maryland United States USPNF.2025b. \u201cUltraviolet\u2010Visible Spectroscopy.\u201dhttps:\/\/doi.org\/10.31003\/USPNF_M3209_04_01.","DOI":"10.31003\/USPNF_M3209_04_01"},{"key":"e_1_2_11_37_1","unstructured":"US Food and Drug Administration Office of Regulatory Affairs Quality.2023. Accessed November 3 2025.https:\/\/www.fda.gov\/media\/73920\/download."},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10098\u2010021\u201002188\u20108"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2022.116553"}],"container-title":["Biomedical Chromatography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bmc.70418","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/bmc.70418","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bmc.70418","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:41:48Z","timestamp":1773380508000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/bmc.70418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1002\/bmc.70418"],"URL":"https:\/\/doi.org\/10.1002\/bmc.70418","archive":["Portico"],"relation":{},"ISSN":["0269-3879","1099-0801"],"issn-type":[{"value":"0269-3879","type":"print"},{"value":"1099-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"2026-01-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70418"}}